<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Calgary_Parts skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Calgary/Parts</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><BUTTON onclick="topFunction()" id="topBtn" title="Go to top">TOP</BUTTON></P><DIV class="collapse navbar-collapse" id="navbarNavDropdown"><UL class="navbar-nav"><LI class="nav-item dropdown"><A class="nav-link underline-animation" href="#" id="navbarDropdownMenuLink" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
                        Project
                    </A><DIV class="dropdown-menu dropdown-menu-center" aria-labelledby="navbarDropdownMenuLink"><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/Description">Description</A><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/CRISPR">CRISPR</A><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/FLP-Beta">FLP-Beta</A><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/Chromatin_Modifying_Elements">CME</A><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/Applied_Design">Product Design</A><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/Model">Modelling</A><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/Software">Software</A><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/Results">Results</A></DIV></LI><LI class="nav-item dropdown"><A class="nav-link underline-animation" href="#" id="navbarDropdownMenuLink" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
                        Notebook
                    </A><DIV class="dropdown-menu dropdown-menu-center" aria-labelledby="navbarDropdownMenuLink"><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/Notebook">Journals</A><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/Protocols">Protocols</A></DIV></LI><LI class="nav-item dropdown"><A class="nav-link underline-animation" href="#" id="navbarDropdownMenuLink" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
                        Team
                    </A><DIV class="dropdown-menu dropdown-menu-center" aria-labelledby="navbarDropdownMenuLink"><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/Team">Team Members</A><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/Attributions">Attributions</A><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/Sponsors">Sponsors</A><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/Contact_Us">Contact Us</A></DIV></LI><LI class="nav-item dropdown"><A class="nav-link underline-animation" href="#" id="navbarDropdownMenuLink" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
                        Human Practices
                    </A><DIV class="dropdown-menu dropdown-menu-center" aria-labelledby="navbarDropdownMenuLink"><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/Human_Practices">Summary</A><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/Human_Practices/Silver">Silver</A><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/Human_Practices/Gold_Integrated">Integrated</A><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/Collaborations">Collaborations</A><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/Public_Engagement">Public Engagement</A><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/Safety">Safety</A></DIV></LI><LI class="nav-item dropdown"><A class="nav-link underline-animation" href="#" id="navbarDropdownMenuLink" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
                        Judging
                    </A><DIV class="dropdown-menu dropdown-menu-center" aria-labelledby="navbarDropdownMenuLink"><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/MedalRequirements">Medal Requirements</A><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/Parts">Parts</A><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/Improve">Improved Part</A><A class="dropdown-item" href="https://2018.igem.org/Team:Calgary/InterLab">Interlab</A></DIV></LI></UL></DIV><P><TITLE>Team:Calgary/Parts - 2018.igem.org</TITLE></P><DIV class="container maincontent"><H1 style="transform: translateY(-50%)" class="infotitle">PARTS</H1><DIV class="infosection"><H3 class="infosubtitle">Parts Collection</H3><P style="text-indent: 0px">Parts <B>BBa_K2605000 to BBa_K2605004 and BBa_K2605009</B> comprise the first
                iteration of a novel toolkit for targeted gene integration and maintenance of expression in eukaryotic
                chassis. The collection contains chromatin-modifying elements that limit silencing of the integrated
                gene and minimize neighborhood effects. These elements, as well as the mCherry-BGH reporter gene with
                our improved CMV promoter, have restriction sites for directional cloning into part BBa_K2605002, which
                is a Multiple Cloning Site (MCS) flanked by distinct FRT (FLP recombinase recognition target) sites.</P><P style="text-indent: 0px">In the first iteration of our gene integration strategy,
                the FRT sites are leveraged for recombinase-mediated casette exchange (RMCE).
                Representing an experimental second design, <B>BBa_K2605006</B> is a prototype part intended to test
                our novel FLP-Beta strategy. For either RMCE or FLP-Beta, the toolkit is intended to leverage
                genome-integrated recombinase target sites.</P><P style="text-indent: 0px">Each part in this collection (except BBa_K2605002 and BBaK260506) is designed
                with two different restriction sites on either end to allow for simple bi-directional cloning. The
                entire MCS is flanked by SapI restriction sites so that the entire cloning site and FRT sites can be
                transferred to different plasmids. AflII restriction sites flank the MCS interior of the FRT sites so
                that only the MCS can be transferred to different plasmids. A schematic of our MCS (BBa_K2605002) can
                be seen below.</P><P style="text-indent: 0px">The figure below shows an example of how chromatin-modifying elements and a
                reporter gene can be used in our system. The restriction sites for bi-directional cloning of each part
                is shown.</P><P style="text-indent: 0px"><B>Our Parts Collection:</B></P><TABLE><TBODY><TR><TH>Part</TH><TH>Name</TH></TR><TR><TD><A href=" http://parts.igem.org/Part:BBa_K2605000" target="blank">BBa_K2605000</A></TD><TD>mCherry + BGH</TD></TR><TR><TD><A href="http://parts.igem.org/Part:BBa_K2605001 " target="blank">BBa_K2605001</A></TD><TD>CMV with 5' SalI restriction site</TD></TR><TR><TD><A href="http://parts.igem.org/Part:BBa_K2605002 " target="blank">BBa_K2605002</A></TD><TD>Multiple cloning site with flanking FRT sites</TD></TR><TR><TD><A href="http://parts.igem.org/Part:BBa_K2605003 " target="blank">BBa_K2605003</A></TD><TD>A2UCOE</TD></TR><TR><TD><A href="http://parts.igem.org/Part:BBa_K2605004" target="blank">BBa_K2605004</A></TD><TD>Chicken beta-globin insulator</TD></TR><TR><TD><A href="http://parts.igem.org/Part:BBa_K2605006" target="blank">BBa_K2605006</A></TD><TD>Hybrid FlpO-beta resolvase</TD></TR><TR><TD><A href="http://parts.igem.org/Part:BBa_K2605009" target="blank">BBa_K2605009</A></TD><TD>CMV with 5' SalI restriction site + mCherry + BGH</TD></TR></TBODY></TABLE><H3 class="infosubtitle">Basic Parts</H3><P><B><A href="http://parts.igem.org/Part:BBa_K2605000 " target="blank"><B>BBa_K2605000</B></A> - mCherry +
                    BGH</B></P><P style="text-indent: 0px">mCherry red fluorescent protein (RFP) codon-optimized for expression in
                human/mammalian cells with a BGH terminator attached. The addition of BGH makes this part an
                improvement of the original mCherry part, <A href="http://parts.igem.org/Part:BBa_J176005" target="blank">BBa_J176005</A>.</P><P><B><A href="http://parts.igem.org/Part:BBa_K2605001 " target="blank"><B>BBa_K2605001</B></A> - CMV with
                    5'
                    SalI restriction site</B></P><P style="text-indent: 0px">Cytomegalovirus (CMV) promoter with an additional 5' SalI site, which allows
                this promoter to be used within our Multiple-Cloning Site flanked by FRT sites. This is an improvement
                of part <A href="http://parts.igem.org/Part:BBa_K747096" target="blank">BBa_K747096</A> and you can
                learn more about its characterization and improvement <A href="https://2018.igem.org/Team:Calgary/Improve">here</A>.</P><P><B><A href="http://parts.igem.org/Part:BBa_K2605002 " target="blank"><B>BBa_K2605002</B></A> - Multiple
                    cloning site with flanking FRT sites</B></P><P style="text-indent: 0px">Multiple Cloning Site (MCS) flanked by distinct FRT (FLP recombinase
                recognition target) sites. The MCS carries sites for an arbitrary construct to be directionally cloned.
                The MCS was designed for our first iteration of targeted gene integration, which involved
                recombinase-mediated casette exchange (RMCE), thus it was flanked by FRT sites.
            </P><P><B><A href="http://parts.igem.org/Part:BBa_K2605003 " target="blank"><B>BBa_K2605003</B></A> - A2UCOE</B></P><P style="text-indent: 0px">A methylation-free CpG island that provides stable and localization of
                integration-independent transgene expression when fused to a eukaryotic promoter. This part contains a
                5' MfeI restriction site and 3' NsiI restriction site so it can be used within our Multiple-Cloning
                Site flanked by FRT sites (BBa_K2605002). </P><P><B><A href="http://parts.igem.org/Part:BBa_K2605004 " target="blank"><B>BBa_K2605004</B></A> - Chicken
                    beta-globin insulator</B></P><P style="text-indent: 0px">DNAse‐I hypersensitive CpG‐rich structure that provides stable and localization
                of integration-independent transgene expression and prevents unrelated enhancer-promoter interactions
                when flanking a transgene. This part contains a 5' BmtI restriction site and 3' BamHI restriction site
                so it can be used within our Multiple-Cloning Site flanked by FRT sites (BBa_K2605002). </P><P><B><A href="http://parts.igem.org/Part:BBa_K2605005 " target="blank"><B>BBa_K2605005</B></A> - FRT2</B></P><P style="text-indent: 0px">A FLP recombinase recognition target (FRT) site.</P><P><B><A href="http://parts.igem.org/Part:BBa_K2605006 " target="blank"><B>BBa_K2605006</B></A> - Hybrid
                    FlpO-beta resolvase</B></P><P style="text-indent: 0px">This part represents a plug-and-play construct to implement the FLP-Beta strategy in a eukaryotic chassis. The coding sequence for FLPo must be added to the same vector or co-delivered with a second. This construct is intended to be subcloned into the MCS of a mammalian expression vector, downstream of a strong promoter and upstream of a terminator. To maximize the efficiency of the system, the expression vector should include a secondary resistance marker (not Puromycin) and an origin of replication to maintain a plasmid population within the cell for as long as is required for the integration reaction to proceed to completion. 
          </P><H3 class="infosubtitle">Composite Parts</H3><P><B><A href="http://parts.igem.org/Part:BBa_K2605007 " target="blank"><B>BBa_K2605007</B></A> - CMV with
                    5'
                    SalI restriction site + monomeric RFP optimized for bacteria</B></P><P style="text-indent: 0px">Part used to characterize and validate the improvement of part BBa_K2605001.
                Read more about its characterization <A href="https://2018.igem.org/Team:Calgary/Improve">here</A>. </P><P><B><A href="http://parts.igem.org/Part:BBa_K2605008 " target="blank"><B>BBa_K2605008</B></A> - CMV +
                    monomeric RFP optimized for bacteria</B></P><P style="text-indent: 0px">Part used to characterize and validate the improvement of part BBa_K2605001.
                Read more about its characterization <A href="https://2018.igem.org/Team:Calgary/Improve">here</A>. </P><P><B><A href="http://parts.igem.org/Part:BBa_K2605009 " target="blank"><B>BBa_K2605009</B></A> - CMV with
                    5'
                    SalI restriction site + mCherry + BGH</B></P><P style="text-indent: 0px">Composite part of BBa_K2605001 (promoter) fused to BBa_K2605000
                (reporter gene). The part contains a SalI restriction site on the 5' end and a BmtI restriction site on
                the 3' end to allow for this part to be used within our Multiple-Cloning Site flanked by FRT sites
                (BBa).</P><P><B><A href="http://parts.igem.org/Part:BBa_K2605010 " target="blank"><B>BBa_K2605010</B></A> - CMV +
                    mCherry + BGH</B></P><P style="text-indent: 0px">Composite part of BBa_K747096 (promoter) fused to BBa_K2605000
                (reporter gene). The part contains a SalI restriction site on the 5' end. </P></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>